Advertisement

Topics

Companies Related to "Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings" [Most Relevant Company Matches] [Advanced Search Results] RSS

11:04 EDT 19th July 2018 | BioPortfolio

Here are the most relevant search results for "Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings" found in our extensive corporate database of over 50,000 company records.

Showing "Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings" Companies 1–25 of 2,800+

Extremely Relevant

Cytori Therapeutics Inc.

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied acro...


Cytori Therapeutics

Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the...

Cytori Therapeutics, Inc.

Cytori is an emerging leader in regenerative medicine, providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution(R) System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets...


Relevant

marc's group ag.

marc’s group is a client-driven European consultancy delivering high-quality, intangible results for Dental and Medical Technology companies. It is our main task to work as a catalyst by creating innovative results from yet unidentified potentials. Our purpose is to offer an international network of competencies for Company Executives in Business Development, Innovation Management and Communicat...

Minnesota Applied Research Center

MARC is a fully equipped clinical research site able to provide a full range of research services. MARC staff are experienced at taking research ideas from conception to completion in a proficient, prompt and cost-effecitve manner. MARC provides consulting services for the design and conduct of clinical trials, the review and monitoring of ongoing trials, as well as the documentation and submiss...

Marc Whitehead & Associates

Marc Whitehead & Associates, Attorneys at Law is based in Houston, Texas and founded on the principles of skill, integrity and professionalism. The law firm has been in business for 25 years, and prides itself on delivering exceptional personal service and unparalleled results in obtaining disability compensation for veterans, claimants of long term dis...

Harbor Retirement Associates

“Since early 2009, Marc has shown unprecedented dedication and commitment to HRA’s core values of respect, attentiveness, integrity, stewardship and excellence,” says Tim Smick. “When Marc joined HRA as Vice President of Sales and Marketing, he immediately executed a growth strategy that raised HRA’s census above industry standards...

Tango Therapeutics

Tango Therapeutics is a biotechnology company developing novel medicines for patients by discovering and drugging context-dependent vulnerabilities in cancers. Tango was launched in 2017 by Third Rock Ventures and is headquartered in Cambridge, Mass. For more information, please visit www.tangotx.com.

Maverick Therapeutics Inc.

Maverick Therapeutics is pioneering the next generation of redirected T cell therapeutics in immuno-oncology. Maverick’s highly innovative platform is designed to deliver potent activity with increased tumor specificity and reduced toxicity, resulting in superior therapeutics for cancer patients and improved clinical success. Maverick was founded by M...

PRTM

PRTM has followed one principle since our founding in 1976—to make a lasting difference for our clients. The only way we can get those kinds of results is to work relentlessly and passionately as a global team with our clients.What does that mean? It means we offer insights with the power to transform the very way a company operates. We live and breathe your ecosystem, your business, your operat...

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file ...

Capital Earnings & Research

MARC Coalition

TM3 Therapeutics

TM3 Therapeutics is focused on novel treatments for neurodegenerative and metabolic diseases by developing unique metabolite replacement therapies. Our goal is to improve survival outcomes and quality of life of patients with rare, genetic neurological diseases that have limited or no treatment options. Our clinical development program specifically targets...

Marc Voci Salon and Colorbar

Xilam Animation

Xilam is an audio-visual and multi-media production company launched by Marc du Pontavice after he bought up all assets of Gaumont Multimédia. Xilam - today a European leader in top-quality animation - creates, produces and distributes youth animated series and their spin-offs for an international market, in various formats: TV, film, videogames et merchandising. Marc du Pontavice, Vice-President...

NAM Asia Hong Kong Co., Ltd.

CEO Teppei Nakano graduated from Keio University School of Medicine in 2017. We have been adopting IPA unexplored projects by the Ministry of Economy, Trade and Industry, which represent a large number of representatives of IT companies representing Japan, twice in 2016 and 2017, independent businesses that have been adopted by unexplored This is the NAM p...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

Ballantyne Strong, Inc.

http://www.strong-world.com (Investor Relations section) or www.earnings.com

Partners Pharmacy

Partners Pharmacy is based in Cranford, N.J., and is the third largest long-term care pharmacy in the United States. Founded in 1998, Partners Pharmacy provides services to more than 60,000 residents around the country. In order to meet the needs of facilities, staff, residents and their families, Partners offers a comprehensive approach to long-term care ...

The Hood Incubator

The Hood Incubator was founded in 2016 to build political and economic power for Black and Brown communities in the rapidly growing cannabis industry. The nonprofit organization fulfils its mission of increasing the participation of Black and Brown communities in the legal cannabis industry through three main areas of work: Community Organizing, Policy Adv...

Ziarco Pharma Ltd.

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting dermatological and inflammatory diseases. ZPL-389, the Company’s lead compound, is an oral histamine H4 receptor antagonist, currently in two Phase 2a studies: the first in atopic dermatitis is fully recruited and will read out in Q2 2016; and the second has ...

Alcresta Therapeutics, Inc.

Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency, which results in malabsorption common in cysti...

Finch Therapeutics Group, Inc.

Finch Therapeutics Group is developing novel microbial therapies to serve patients with serious unmet medical needs. Founded by data scientists, clinicians, and microbiologists from MIT and OpenBiome, Finch uses innovative machine-learning algorithms informed by high-throughput molecular data to reverse engineer successful clinical experience, building upo...

Vitruvias Therapeutics Inc.

Vitruvias is a generic pharmaceutical company which utilizes domestic and international partnerships to develop, manufacture, and market technically difficult generic products. Founded in 2013, the company’s primarily focus is on products in the generic sterile injectable market. The Company received its first approval in September 2017, and anticipat...


More From BioPortfolio on "Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks